Abstract. The rapid prototyping (RP) technology has advanced in various fields such as verification of design, and functional test. Recently, researchers have studied bio-materials to fabricate functional bio-RP parts. In this research, a nano composite deposition system (NCDS) was developed to fabricate three-dimensional functional parts for bio-applications. In the hybrid process, the material removal process by mechanical micro machining and/or the deposition process are combined. NCDS uses biocompatible or biodegradable polymer resin as matrix and various bioceramics to form bio-composite materials. To test drug release rate in vivo environment, two different types of drug delivery system (DDS) were fabricated using the bio-composite materials. 1) Container type DDS used poly(DL-lactide-co-glycolide acid)(50:50) and 5-fluorouracil as the drug composite while polycaprolactone(PCL) served as the container of the drug. 2) Scaffold type DDS formed porous microstructure with poly(DL-lactide-co-glycolide acid)(50:50) and 5-fluorouracil composite. The effect of geometry of the DDS on release rate of drug is under investigation.
Introduction
The Rapid Prototyping technology has advanced in product development cycle since 1980s. One of the new approaches in recent RP technology is application to micro parts [1, 2] . Other new fields of RP research include bio and medical applications where simulation of operation is performed using RP models, and artificial bones made by RP process are implanted into human body [3] [4] [5] [6] [7] [8] . As an example, an implantable drug delivery system (DDS) was developed using micro fabrication and RP technique [9] . Such devices would permanently remain in the biological tissue if not removed surgically. Because of inherent difficulty associated with retrieving small-scale devices from tissues, it is advantageous to apply biodegradable polymers, such that the micro-devices would naturally degrade and disappear in tissues over a desired period of time.
On the material issue, wide acceptability of the biodegradable system can be appreciated from the fact that biodegradability can be manipulated. Biodegradation can be enzymatic, chemical or of microbial origin or simply by hydrolysis [10] . An attractive approach for the delivery of pharmacologically active compound is the controlled and sustained release of active agents from a resorbable polymeric delivery system that is implanted next to the diseased tissue [11] .
Among biodegradable polymers, polylactic acid and poly(lactic/glycolic) acid (PLGA) have been the most commonly used in sustained-release drug delivery, as they degrade by simple hydrolysis of the ester bonds into natural metabolites, glycolic and lactic acid. These polymers are therefore biocompatible, biodegradable and considered safe [12, 13] . Polycaprolactone (PCL), aliphatic polyester, is one of the important biodegradable polymers in medicine. Some of the applications of PCL are sutures and biocompatible medical devices [14] . In the emerging field of tissue engineering, biodegradable polymers are used for realizing polymer scaffolds to assist tissue and cell growth during formation of artificial organs [15] .
In this research, a nano composite deposition system (NCDS) was developed to fabricate DDS. As a drug material, 5-fluorouracil was used to form a polymer-drug composite.
Nano Composite Deposition System (NCDS)
NCDS was constructed to fabricate bio-composite with various applications.
Hardware system
NCDS consists of two main parts ( Fig. 1 (a) ), one is deposition system and the other is machining system. The detailed specification of NCDS is listed in Table 1 . The 3-axis stage had linear encoder at each axis, which provided 1㎛ resolution, and the stage was controlled by PMAC control board. Fig. 1 (b) shows the deposition needle and a magnified view of the micro endmill. Fig. 1 . Hardware system of (a) nano composite deposition system(NCDS), and (b) deposition and cutting tools of NCDS. 
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Process planning
NCDS consists of deposition mechanism and material removal process of "mechanical micro machining" in the 3 axis-stage. Fig. 2 shows the typical process of NCDS that 1) deposits molten nano composite material, 2) solidifies the polymer in the room temperature, and 3) mills out the unnecessary deposited materials by micro machining if necessary. By repeating the deposition and machining processes for each layer, final three-dimensional part with certain height (in z-direction) was available.
Experimental
Two different shapes of the drug delivery device were fabricated by NCDS, container type and scaffold type.
Fabrication of specimens
Materials
In this research, PLGA50:50 (Poly(DL-lactide-co-glycolide acid)) and PCL (polycaprolactone) were used as matrix material. PLGA50:50 and PCL are thermo plastic those melt near 60℃. 5-fluorouracil (5-FU) was used as antineoplastic drug. The high shear mixing method was used to form a drug-polymer composite.
Container Type Specimen
For this type of drug delivery device, PCL was used as a container of the drug, and PLGA50:50+5-FU was used as polymer-drug composite. Fig. 3(a) shows the schematic diagram and dimensions of the DDS. After molding PCL containers from the aluminum mold (Fig. 3b) , polymer-drug composite was deposited in the PCL containers using NCDS. 
Scaffold Type Specimen
Scaffold type DDS was fabricated with polymer-drug composite. For the scaffold, only deposition system of NCDS was used during fabrication. Fabricated scaffold shows almost uniform pore size. Fig. 4 shows microstructure of the fabricated scaffold. It was possible to fabricate different pore size of scaffold by simply changing the process parameters. 
Key Engineering Materials Vols. 342-343
Conclusions
NCDS is a hybrid RP process that may fabricate precise meso scale parts using various materials including composites. Among many possible DDS geometry two types of polymer-particle composite DDS were fabricated. The container type DDS is easy to measure its release rate because of one-directional release through the open end of drug while the scaffold type DDS provides fast but complicate release because the pores provide large surface areas of drug-polymer composite in vivo fluids. The effect of geometry of the DDS on release rate of drug is under investigation.
